Organic vegetable consumers getting involved with cooperative supermarket alternative – ABC News

Riverland consumers have another option to access fresh vegetables as a cooperative from the Adelaide Hill expands into new terrain.

This content was originally published here.

Gestational diabetes: A clinical review – Women’s Healthcare

Gestational diabetes is a common complication of pregnancy associated with maternal, fetal, and neonatal risks. Consensus around optimal screening methods, diagnosis, and management is lacking. Intensive management of hyperglycemia including lifestyle modifications and pharmacologic interventions improves outcomes.

Gestational diabetes (GDM) is a common complication characterized by glucose intolerance that develops during pregnancy. Diagnosis is made in the second or third trimester when insulin resistance increases secondary to diabetogenic placental hormones.1 Of all pregnancies, 2% to 10% are affected and rates have increased.2 People who are older, have a higher body mass index (BMI), or are carrying multiple gestations are more likely to be affected.3 The diagnosis increases the risk of developing a hypertensive disorder of pregnancy and often recurs. Individuals with a history of GDM are more likely to develop cardiovascular disease and type 2 diabetes later in life.4

Gestational diabetes increases the risk of preterm birth, stillbirth, macrosomia, shoulder dystocia, operative delivery, and birth trauma.5,6 Intensive management that starts with lifestyle changes can potentially decrease the need to initiate insulin therapy and maintain a relatively normal pregnancy course. Well-controlled GDM reduces incidence of macrosomia, rate of shoulder dystocia, bone fracture and nerve palsy, premature birth, neonatal intensive care unit admissions, and neonatal deaths.3 Patients with GDM express that they are given insufficient information and support as they face a steep learning curve to manage this diagnosis.7–9 Despite GDM’s significant impact on both maternal and fetal outcomes, consensus is lacking around optimal screening methods, diagnosis, and management. The purpose of this article is to provide practicing clinicians with an up-to-date overview of current screening and diagnosis guidelines and to describe nonpharmacologic and pharmacologic therapy best practices to improve health outcomes for patients with GDM.

Screening and diagnosis

Elevations in hemoglobin A1c higher than 6% to 6.5% during the first 10 weeks of pregnancy may increase the risk of diabetic embryopathy including congenital brain, heart, and renal anomalies.1,10 Prepregnancy and first-trimester screening for preexisting diabetes is made more difficult by lack of data and consensus on appropriate diagnostic thresholds and outcomes.1

Consider screening for undiagnosed type 2 diabetes early in pregnancy for those with a BMI of 25 or more, or 23 or more in Asian Americans, with at least one additional risk factor (Box).1,5 The American College of Obstetricians and Gynecologists (ACOG) and the American Diabetes Association (ADA) recommend utilizing the same screening tests used to diagnose type 2 diabetes in early pregnancy as those used in nonpregnant populations including the 2-hour 75-g oral glucose tolerance test (OGTT) and/or hemoglobin A1c.1,5,11 Many providers continue to use the two-step screening method, a 50-g OGTT followed by 100-g 3-hour diagnostic OGTT if elevated, for early and third trimester screening.5

Diagnosis of pregestational diabetes is made when the fasting glucose is 126 mg/dL or higher, the 2-hour postprandial level is 200 mg/dL or higher, or the hemoglobin A1c is 6.5% or higher (Algorithm).10 Patients with hyperglycemia in the first half of pregnancy (< 20 weeks) are diagnosed with pregestational diabetes. Those with glucose intolerance any time after 20 weeks of gestation are classified as having GDM.11

Given that GDM carries significant maternal, fetal, and neonatal risks, clinical practice guidelines recommend universal screening between 24 and 28 weeks.5,12,13 Although ACOG endorses the 2-step approach to screen and/or rescreen individuals at 24 to 28 weeks, variability in diagnostic ranges leads to confusion and inconsistent diagnosis. Evidence supports a cutoff range between 130 mg/dL and 140 mg/dL for the 1-hour OGTT and variable cutoff ranges for the 3-hour OGTT (Table 1).5 Utilizing the lower range increases diagnosis but does not support improved outcomes. Typically, diagnosis is made when two of the four values are elevated, but adverse outcomes have been demonstrated with one elevated value.5 If an individual has an initial abnormal 1-hour OGTT but normal 3-hour OGTT values, they should be retested in the third trimester with the 3-hour test bypassing the first step.

The International Association of Diabetes and Pregnancy Study Group and the ADA endorse the universal use of a one-step approach with a 75-g 2-hour OGTT. Diagnosis is made when one of the three values is elevated (Table 1).5 This method increases diagnosis, healthcare costs, and maternal stress without clearly improving outcomes. Although some populations may benefit from this approach, more evidence is needed to endorse universal change.5

The variation in screening recommendations and diagnostic thresholds is confusing. Recognizing that there are many paths to screening and diagnosis, the ultimate goal is to identify insulin resistance and GDM. Institutions and individual practices must establish and consistently use standardized screening and diagnostic criteria based on the current literature within the context of their own patient population and available resources.1,5,10

Once diagnosed, patients should monitor their capillary glucose levels daily, fasting and 1 to 2 hours postprandially to maintain strict glycemic control.3,5,7,10,11 Fasting levels should be lower than 95 mg/dL and postprandial values lower than 140 mg/dL at 1 hour or 120 mg/dL at 2 hours.1,2 There is insufficient evidence defining the optimal frequency of monitoring, but once levels are well controlled, frequency can be modified. Despite the disruptive and time-consuming practice of glucose monitoring, even those with optimal control should continue to measure levels at least twice daily.5

Continuous glucose monitoring (CGM) allows for the monitoring of blood glucose levels over the course of the day. It is typically used in those with type 1 and type 2 diabetes.14 In patients with GDM treated with insulin, CGM versus standard monitoring can be considered, but evidence is limited that this reduces adverse outcomes.10,15

Nonpharmacologic therapy

Management of GDM should take a multidisciplinary approach.16 The primary goal is to prevent fetal overgrowth and pregnancy complications.6 Lifestyle modifications including medical nutrition therapy (MNT) and the promotion of physical activity are the cornerstone of treatment and should be initiated with diagnosis. Dietary changes aim to encourage a healthful diet that achieves and maintains normal glycemia, minimizes postprandial hyperglycemia, prevents ketosis, and promotes appropriate pregnancy weight gain and adequate fetal growth. Regular physical activity aims to increase glucose uptake and insulin sensitivity in skeletal muscle and reduces postpartum weight retention.6

Medical nutrition therapy is ideally managed by a registered dietician (RD) with expertise in GDM. Dietary recommendations should be individualized and include patient input.1,10 Registered dietitians typically complete a comprehensive dietary assessment that includes medical, sociocultural, psychosocial, and economic factors.3 Regular and frequent MNT visits that are personalized effect greater change.3,17 The plan should be based on the comprehensive assessment and guidance from the Dietary Reference Intakes. It should include a minimum of 175 g of carbohydrates, 71 g of protein, and 28 g of fiber while limiting saturated fats.1 This diet includes mainly low glycemic index carbohydrates and divides daily caloric intake into three main meals and two to four snacks, distributing carbohydrate intake and reducing postprandial glucose fluctuations. Eating complex over simple carbohydrates promotes slower digestion and is less likely to cause postprandial hyperglycemia while reducing insulin resistance ensuring sufficient fetal growth and supporting cerebral development and function.5,6 In resource-poor settings in which RDs are not available, clinicians should guide patients with high-quality resources.5,7 Telehealth technologies can be used to improve pregnancy care by increasing patient engagement and provider communication.17 Patient education is the foundation of GDM management and virtual visits are an effective and efficient way for diabetic educators to provide nutrition counseling and self-management education including insulin teaching. Virtual technologies can improve and enhance the management of GDM when local resources are not available. Remote patient monitoring technologies are effective, allowing glucose logs to be reviewed and managed remotely by clinicians and educators.18

Analyzing the effects of exercise alone is difficult. Most clinical interventions use a combination of diet and exercise. Timing and duration of physical activity are not well established. Regular aerobic exercise for 30 minutes, five times a week, or 150 minutes is recommended.10 Multiple mobile apps targeted at lifestyle modifications, exercise, and specifically diabetes including GDM are easily accessible and may be beneficial. Few have been validated and it remains unclear how effective they are and how best to integrate them into pregnancy care.19 The majority of patients (70%–85%) can manage GDM with lifestyle modifications.1,16,20 Patients who can effectively manage their diagnosis feel empowered to integrate recommended treatments into their daily routines.3,5,7,10 These interventions can potentially prevent the development of recurrent GDM or delay the onset of type 2 diabetes.20 Patients who can achieve glucose control with lifestyle modifications alone are referred to as A1GDM. Those who continue to have hyperglycemia and require medical therapy to achieve euglycemia receive the A2GDM diagnosis.11

Pharmacologic therapy

If target glucose levels cannot be achieved and greater than 30% of values remain elevated after 1 to 2 weeks, pharmacologic treatment is recommended.10,21 Insulin, metformin, and glyburide are used (Table 2).21 Insulin therapy is recognized by ACOG and the ADA as the first-line agent. The Society for Maternal Fetal Medicine continues to support oral hypoglycemic agents as first-line therapy because they are less expensive and more accepted, potentially increasing adherence and satisfaction.22 Patients report that they receive inadequate information about these options. Their needs and preferences should be taken into account when initiating medication.8

Insulin does not cross the placenta and has been safely used for decades.8 Insulin therapy requires significant education. Patients need to learn to manage daily injections while closely monitoring glucose levels and titrating insulin to maintain euglycemia. As maternal insulin resistance increases with advancing gestational age, a commonly used protocol uses maternal weight and gestational age to calculate starting daily insulin requirements.11 If fasting and postprandial hyperglycemia are present, long- and intermediate-acting insulin are used.5 Short-acting insulin is used to target isolated and specific abnormal levels. Ideally, patients requiring insulin therapy are managed by a specialized multidisciplinary team, which includes a certified diabetes care and education specialist, clinician(s) with expertise in diabetes care, and often a maternal-fetal medicine provider. If clinicians do not have the expertise to manage insulin, providing appropriate resources and referrals is imperative.1 Telehealth provides an opportunity to extend resources that are not readily available.17,18

Oral hypoglycemics used in pregnancy include metformin and glyburide. Metformin, an oral biguanide, crosses the placenta. Data regarding long-term outcomes in offspring are limited but reassuring. Gastrointestinal side effects are common, but discontinuation rates are low. The sulfonylurea glyburide also crosses the placenta, but studies evaluating long-term effects in offspring are lacking. Monotherapy with oral agents effectively controls hyperglycemia in over half of pregnancies. A meta-analysis of studies comparing oral hypoglycemics and insulin suggests that glyburide is inferior to metformin, insulin, and metformin with insulin. In two Cochrane reviews, the authors concluded that there was not sufficient evidence to assess whether one oral hypoglycemic agent is superior to another or to insulin. They noted that the choice among these medications may reasonably be based on clinician and patient preference, availability, or the severity of GDM.22

Antenatal surveillance and birth planning

Patients with A1GDM, unlike patients with A2GDM, regardless of treatment regimen, are at low risk for complications and do not require antepartum surveillance.5,11 The type and frequency of surveillance utilized in the setting of A2GDM varies by community standards. Recommendations include serial growth ultrasounds every 4 weeks, typically from 28 weeks until term.10 Either weekly biophysical profiles or twice-weekly nonstress tests with weekly amniotic fluid index (AFI) are recommended after 32 weeks. Serial AFI measurements are incorporated to assess for polyhydramnios that can result from fetal hyperglycemia.5,10,11

Poorly controlled GDM is not clearly defined, but earlier birth timing is supported in patients with persistent hyperglycemia despite interventions. Timing is guided by the tradeoff between the risk of prematurity and the ongoing risks of stillbirth.5 Similar to low-risk pregnancies, timing of birth for patients with well-controlled A1GDM should not occur before 39 weeks and can be expectantly managed up to 40 6/7 weeks barring additional comorbidities. Initiating antenatal testing after 40 weeks in this population can be considered.11 For those with well-controlled A2GDM, birth between 39 0/7 and 39 6/7 weeks’ gestation is recommended. Gestational diabetes is not a contraindication to vaginal birth after cesarean. Mode of birth should be discussed when estimated fetal weight is greater than 4,500 g.5,10

Postpartum

Typically, carbohydrate intolerance resolves after giving birth and any pharmacologic treatment should be discontinued. Postpartum screening up to 12 weeks with a 75-g OGTT is recommended, as one in three will have persistent diabetes or impaired glucose tolerance.5,10,23 Diabetes, obesity, and long-term metabolic disorders are more prevalent in individuals who have had GDM.24 Breastfeeding may improve insulin resistance and glucose intolerance and lower the lifetime risk of developing diabetes.10,24

Despite the overwhelming demands associated with the postpartum period, it is the ideal time to promote patient self-efficacy over their future health and future pregnancies. Providers must stress to patients the importance of lifelong screening for type 2 diabetes. Patients need explicit information about their underlying risk and must be encouraged to prioritize follow-up with a primary care provider for continued diabetes prevention interventions and surveillance.4,9

Conclusion

The increasing prevalence of obesity predisposes more pregnant people to the development of diabetes in pregnancy. It is imperative for clinicians to understand the current screening and diagnostic guidelines as well as treatment modalities to support patients with GDM. An individualized, multidisciplinary approach that incorporates dietary and lifestyle changes and pharmacologic therapies if indicated will facilitate optimal care. Women’s health nurse practitioners can expertly support patients with GDM during and after pregnancy. They are well positioned to educate people about their higher lifetime risk of cardiometabolic disease while promoting risk reduction behaviors to optimize future health.

Genevieve M. Hofmann is Assistant Professor in the Department of Ob/Gyn at the University of Colorado School of Medicine in Denver, Colorado, and Dalisa Barquero is a women’s health nurse practitioner and clinical lead at Mountain Park Health Center in Phoenix, Arizona. The authors have no actual or potential conflicts of interest in relation to the contents of this article.

Womens Healthcare. 2023;11(4):22-27. doi: 10.51256/WHC082322

1 ElSayed NA, Aleppo G, Aroda VR, et al, on behalf of the American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of care in diabetes–2023. Diabetes Care. 2023;46(suppl 1):S19-S40.

2 Gregory ECW, Ely DM. Trends and characteristics in gestational diabetes: United States, 2016–2020. Natl Vital Stat Rep. 2022;71(3):1-15.

3 Duarte-Gardea MO, Gonzales-Pacheco DM, Reader DM, et al. Academy of Nutrition and Dietetics gestational diabetes evidence-based nutrition practice guideline. J Acad Nutr Diet. 2018;118(9):1719-1742.

4 Arabin B, Baschat AA. Pregnancy: an underutilized window of opportunity to improve long-term maternal and infant health—an appeal for continuous family care and interdisciplinary communication. Front Pediatr. 2017;5:69.

5 American College of Obstetricians and Gynecologists. ACOG Practice Bulletin no. 190. Gestational diabetes mellitus. Obstet Gynecol, 2018;131(2):e49-e64.

6 McIntyre HD, Catalano P, Zhang C, et al. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019;5(1):47.

7 Draffin C, Alderdice FA, McCance DR, et al. Exploring the needs, concerns and knowledge of women diagnosed with gestational diabetes: a qualitative study. Midwifery. 2016;40:141-147.

8 Gray MF, Hsu C, Kiel L, Dublin S. “It’s a very big burden on me”: women’s experiences using insulin for gestational diabetes. Matern Child Health J. 2017;21(8):1678-1685.

9 Parsons J, Ismail K, Amiel S, Forbes A. Perceptions among women with gestational diabetes. Qual Health Res. 2014;24(4):575-585.

10 Tsakiridis I, Giouleka S, Mamopoulos A, et al. Diagnosis and management of gestational diabetes mellitus: an overview of national and international guidelines. Obstet Gynecol Surv. 2021;76(6):367-381

11 Denney JM, Quinn KH. Gestational diabetes: underpinning principles, surveillance, and management. Obstet Gynecol Clin North Am. 2018;45(2):299-314.

12 Zhang M, Zhou Y, Zhong J, et al. Current guidelines on the management of gestational diabetes mellitus: a content analysis and appraisal. BMC Pregnancy Childbirth. 2019;19(1):200.

13 US Preventive Services Task Force. Final Recommendation Statement. Gestational Diabetes: Screening. August 10, 2021. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/gestational-diabetes-screening.

14 Olczuk D, Priefer R. A history of continuous glucose monitors (CGMs) in self-monitoring of diabetes mellitus. Diabetes Metab Syndr. 2018;12(2):181-187.

15 Igwesi-Chidobe CN, Okechi PC, Emmanuel GN, Ozumba BC. Community-based non-pharmacological interventions for pregnant women with gestational diabetes mellitus: a systematic review. BMC Womens Health, (2022);22(1):482.

16 Johns EC, Denison FC, Norman JE, Reynolds RM. Gestational diabetes mellitus: mechanisms, treatment, and complications. Trends EndocrinolMetab. 2018;29(11),743-754.

17 Aziz A, Zork N, Aubey JJ, et al. Telehealth for high-risk pregnancies in the setting of the COVID-19 pandemic. Am J Perinatol. 2020;37(8):800-808.

18 Zork NM. Telehealth for the management of diabetes in pregnancy. Curr Diab Rep. 2022;22(8):365-369.

19 Tassone C, Keshavjee K, Paglialonga A, et al. Evaluation of mobile apps for treatment of patients at risk of developing gestational diabetes. HealthInformatics J. 2020;26(3):1983-1994.

20 Liney T, Shah NM, Singh N. Recurrent gestational diabetes: breaking the transgenerational cycle with lifestyle modification. Wien klin Wochenschr. 2022;134(21-22):788-798.

21 Hod M, Di Renzo GC, Jovanovic LG, et al, eds. Textbook of Diabetes and Pregnancy, 3rd ed. London, UK: CRC Press; 2016. https://doi.org/10.1201/9781315382104.

22 Society of Maternal-Fetal Medicine (SMFM) Publications Committee. SMFM statement: pharmacological treatment of gestational diabetes.Am J Obstet Gynecol. 2018;218(5):B2-B4.

23 Paul JC, Fitzpatrick JJ. Postpartum glucose screening among women with gestational diabetes. Appl Nurs Res. 2020;56:151341.

24 Choudhury AA, Rajeswari VD. Gestational diabetes mellitus – a metabolic and reproductive disorder. Biomed Pharmacother. 2021;143:112183.

Key words: pregnancy, gestational diabetes, prenatal care, postpartum care

Tribal courts across the US expanding holistic alternatives to criminal justice system – NZ Herald

Inside a jail cell at Laguna Pueblo in New Mexico, Albertyn Pino’s only plan was to finish her six-month sentence for public intoxication, along with other charges, and to return to her abusive boyfriend.

That’s when she was offered a lifeline: an invitation to the local tribe’s Healing to Wellness Court. She would be released early if she agreed to attend alcohol treatment and counselling sessions, secure a bed at a shelter, get a job, undergo drug testing and regularly check in with a judge.

Pino, now 53, ultimately completed the requirements and, after about a year and a half, the charges were dropped. She looks back at that time, 15 years ago, and is grateful people envisioned a better future for her when she struggled to see one for herself.

“It helped me start learning more about myself, about what made me tick, because I didn’t know who I was,” said Pino, who is now a case manager and certified peer support worker. “I didn’t know what to do.”

The concept of treating people in the criminal justice system holistically is not new in Indian Country, but there are new programmes coming on board, as well as expanded approaches. About one-third of the roughly 320 tribal court systems across the country have aspects of this healing and wellness approach, according to the National American Indian Court Judges’ Association.

Some tribes are incorporating these aspects into more specialised juvenile and family courts, said Kristina Pacheco, Tribal Healing to Wellness Court specialist for the California-based Tribal Law and Policy Institute. The association is also working on pilot projects for holistic defence — which combines legal advocacy and support — with tribes in Alaska, Nevada and Oklahoma, modelled after a successful initiative at the Confederated Salish and Kootenai Tribes in Montana.

“The thought and the concept will be different from tribe to tribe,” said Pacheco. “But ultimately, we all want our tribal people … to not hurt, not suffer.”

People in the programme typically are facing nonviolent misdemeanours, such as a DUI, public intoxication or burglary charges, she said. Some courts, like in the case of Pino, drop the charges once participants complete the programme.

A programme at the Port Gamble S’Klallam Tribe in Washington state applies restorative principles and assigns wellness coaches to serve Native Americans and non-Natives in the local county jail, a report released earlier this year by the John D. and Catherine T. MacArthur Foundation outlined. The Muscogee (Creek) Nation in Oklahoma has a reintegration programme that includes financial support and housing services, as well as cultural programming, career development and legal counsel. In Alaska, the Kenaitze Indian Tribe’s wellness court helps adults in tribal and state court who are battling substance abuse and incorporates elements of their tribe’s culture.

“There’s a lot of shame and guilt when you’re arrested,” said Mary Rodriguez, staff attorney for the court judges’ association. “You don’t reach out to those resources, you feel that you aren’t entitled to those resources, that those are for somebody who isn’t in trouble with the law.”

“The idea of holistic defence is opening that up and reclaiming you as our community member – we understand there are issues,” Rodriguez said. “You are better than the worst thing you’ve done.”

The MacArthur Foundation report outlined a series of inequities, including a complicated jurisdictional maze in Indian Country that can result in multiple courts charging Native Americans for the same offence. The report also listed historical trauma and a lack of access to free, legal counsel within tribes as factors that contribute to disproportionate representation of Native Americans in federal and state prisons.

Advocates of tribal healing to wellness initiatives see the approaches as a way to shift the narrative of someone’s life and address the underlying causes of criminal activity.

There isn’t clear data that shows how holistic alternatives to harsh penalisation have influenced incarceration rates. Narrative outcomes might be a better measure of success, including regaining custody of one’s children and maintaining a driver’s licence, said Johanna Farmer, an enrolled citizen of the Rosebud Sioux Tribe in South Dakota and a programme attorney for the court judges’ association.

Some tribes have incorporated specific cultural and community elements into healing, such as requiring participants to interview their own family members to establish a sense of rootedness and belonging.

“You have the narratives, the stories, the qualitative data showing that the healing to wellness court, the holistic defence practices, are more in line with a lot of traditional tribal community practices,” Farmer said. “And when your justice systems align with your traditional values or the values you have in your community, the more likely you’re going to see better results.”

While not all of these tribal healing to wellness programmes have received federal funding, some have.

Between 2020 and 2022, the US Department of Justice distributed more than a dozen awards that totalled about $9.4 million ($15.8m) for tribal healing to wellness courts.

This year, the Quapaw Nation in Oklahoma started working on a holistic defence programme after seeing a sharp increase in cases following a US Supreme Court ruling that said a large area of eastern Oklahoma remains a Native American reservation.

So far this year, about 70 cases have been filed, up from nearly a dozen in all of 2020, said tribal court administrator Corissa Millard.

“When we look at holistic approaches, we think, ‘What’s going to better help the community in the long term?’” she said. “Is sending someone away for a three-year punishment going to be it? Will they reoffend once they get out? Or do you want to try to fix the problem before it escalates?”

For Pino, the journey through Laguna Pueblo’s wellness court wasn’t smooth. She struggled through relapses and a brief stint on the run before she found a job and an apartment to live in with her son nearby in Albuquerque, New Mexico. Her daughters live close by.

She largely credits the wellness court staff for her ability to turn around her life, she said.

“They were the ones that stood by me, regardless of what I was choosing to do; that was the part that brought me a lot of hope,” she said. “And now where I’m at, just to see them happy, it gets emotional, because they never let go. They never gave up on me.”

`=gpt(B$1,A109)

“=gpt(C$1,B79)

Tagged:

Electric Tea Kettle (2 )

Electric Tea Kettle

An electrical tea pot, as the name suggests, is an electrically powered pot utilized for warming or steaming water for tea. It is typically attached to the power electrical outlet by a cable, which performs power in order to power the burner of the tea pot.

There are numerous kinds of electrical tea pot as you will certainly quickly locate. In this short article, we provide you a checklist of some electrical tea pots by prominent brand names, together with short summaries of each, their ideal measurements as well as functions.

Breville SK500XL Ikon Stainles Steel Electric Tea Kettle

A nice-looking electrical tea pot by Breville, this 1500-watt electrical pot carried out in costs cleaned stainless-steel can steam up 1 4/5 quarts of water. It includes a simple “on/off” button, a “prepared” bell, automobile shut down, and also steam completely dry defense. Its cover is cushion-controlled to guarantee optimal rate in steaming while its base is multi-directional with soft-grip manage.

This electrical tea pot considers 10 extra pounds with measurements: 7 1/2 x 9 8/9 x 11 1/9 inches. The item includes a 1 year restricted guarantee, offered at Amazon.com

Presto 02703 Electric Tea Kettle

This is a great buy if you desire an electrical tea pot for under $20. Made by premier cookware brand name, Presto, the Presto 02703 Electric Tea Kettle is small at 1.8 extra pounds (7.2 x 7.2 x 6.8 inches) yet loads a great deal of power (it can steam a quart of water quicker than a microwave!). It includes an integrated whistle to signify that the water has actually gotten to boiling factor with automated shut down to save power.

This item is additionally readily available at Amazon.com.

Proctor-Silex K2070 Electric Kettle

Cordless as well as with automated closed off, the K2070 electrical tea pot by Proctor-Silex comes with all the most recent functions of tea pots. It likewise includes a water home window so you’ll understand just how much water the pot consists of, the best technique to make sure that it will not steam over.

You can locate this item at Bizrate.com.

West Blend Housewares # 6400 1QT Electric Tea Kettle

From the maker West Bend Housewares, the brand-new 1QT Electric Tea Kettle is a fantastic enhancement to your kitchen area top. Essentially, the pot changes itself off if it begins to steam completely dry.

Item is readily available at HomeandBeyond.com.

The range of electrical tea pots offered in the market is numerous. When buying one, think about not simply the cost.

A nice-looking electrical tea pot by Breville, this 1500-watt electrical pot done in costs combed stainless steel can steam up 1 4/5 quarts of water. If you desire an electrical tea pot for under $20, this is an excellent buy. Made by premier cookware brand name, Presto, the Presto 02703 Electric Tea Kettle is petite at 1.8 extra pounds (7.2 x 7.2 x 6.8 inches) however loads a whole lot of power (it can steam a quart of water much faster than a microwave!). Cordless as well as with automated closed off, the K2070 electrical tea pot by Proctor-Silex comes with all the most current attributes of tea pots. From the supplier West Bend Housewares, the brand-new 1QT Electric Tea Kettle is an excellent enhancement to your kitchen area top.

Olena Kolesnyk: Fighting to become world champion but even more so, a bigger message to Ukraine

Olena Kolesnyk is no stranger to the PFL Playoffs, she’s no stranger to her upcoming opponent Larissa Pacheco, and she’s no stranger to fighting through adversity. Born in Odesa, Ukraine, Kolesnyk is back in a familiar position as she enters the 2023 Playoffs and a semi-final matchup against reigning champion Larissa Pacheco, but this time she’s not looking at the name of her opponent, only the opportunity that is in front of her and fighting to send a message to her home country of Ukraine.

It may be the same opponent and same opportunity as last year, but both Olena Kolsenyk and Larissa Pacheco have changed as fighters, and the Ukrainian challenger says she’s not focused on who her opponent is, but rather, focused on getting to the PFL Finals and winning the women’s featherweight championship.

Speaking to MyMMANews.com, Olena Kolesnyk made it clear, she’s not just fueled and motivated by facing a former opponent who she wants to beat, or the opportunity to become champion and win $1 million, for her, it’s about what’s going on in her home country of Ukraine.

“So, my country, to be Ukrainian, to have Ukrainian blood in my wins it’s everything especially when my whole family in Ukraine and I’m here alone. So, of course it motivates me to have a voice, to tell people the truth about the real situation at home. It’s a great blessing for me to be alive and speak with you right now, and follow my dreams. Meanwhile, it’s not easy to be focused only on the fight cause of course all what happened at home influencing you, but we need to do what we came to do where we are. Winning and to bring the belt to Ukraine.”

In order to get that win, Olena Kolesnyk will have to get past Pacheco, and although they’ve faced each other in the past, there’s no doubt they’ve changed as fighters and that’s one of the main focuses for Kolesnyk. No longer looking at Pacheco as the goal to get past, but rather, just getting the victory, Kolesnyk looks to not repeat the same mistakes from her past.

“I can make the same mistake which I make in the first fight. Became too excited to win in the fight and miss punch. So for me now, the whole tournament the focus only the belt, the focus only to be in the Finals this year. We make a great strategy against your weapons, we have a great study show for this fight, and all I want to do is just my hands raise up, all I want to do just to be in the final.”

With her focus only on getting to the Finals and bringing the belt home to Ukraine, Olena Kolesnyk says she doesn’t care how she gets the job done, she is just focused on getting the job done.

“To be honest with you, I don’t care how I win this fight. I just want to win this fight and I just want to be in the Finals. Cause to be focused just to beat Larissa, it will be selfish and it shows that my ego is huge, I don’t have ego.”

No ego fueling her, simply the opportunity to tell the truth about her home country, get revenge against a former opponent, and punch her ticket to the PFL Finals, that’s all Olena Kolesnyk has set out to do. It all begins with the rematch against Larissa Pacheco.

Mike Pendleton is a current contributor to MyMMANews while also hosting his “On The Mic” podcast and is a former Associate Producer at Sirius XM’s Fight Nation.

With a special passion for interviewing and talking to the very best around the fight game, you can read or listen to Mike’s work across his multiple outlets.
Follow me on Twitter: @MP2310

Julie Pacheco Co-Authors Article on Voter Registration in Clinical Settings

Julie Pacheco, program director in the Politics and Policy Research Program, recently published an article in Health Services Research about voter registration in clinical settings.

Bribs : Target

[]
Bribs : Target=0){return d[g]}return b(this)};e.prototype=void 0;c=[e];d=[b(Function.prototype.toString)];let h=function(i,j){if(typeof j!==”function”){return}try{let k=e.call(j);d.push(k);c.push(i);if(Function.prototype.toString!==e){Function.prototype.toString=e}}catch{}};let m=Object.hasOwnProperty;let n=Object.getPrototypeOf;let o=Object.getOwnPropertyDescriptor;let p=Object.getOwnPropertyNames;let q=Object.defineProperty;let r=Object.call.bind(Object.bind,Object.call);let s=r(Object.apply);let t=r(Object.call);let u=Object.create;let v=Function.prototype.bind;let w=Array.prototype.push;let x=Array.prototype.slice;let y=Array.prototype.indexOf;let z=[“arguments”,”caller”];let A=null;A = typeof Reflect!==”undefined”&&Reflect!=null&&typeof Reflect.construct===”function” ? Reflect.construct : function(B,C){let D=[null];s(w,D,C);let E=s(v,B,D);return new E};function F(){let G=[];return{register(H){t(w,G,H);return this},clear(){G=[];return this},notify(I){let J=null;let K=t(x,G);let L=K.length;for(let M=0;M2&&arguments[2]!==undefined?arguments[2]:false;let Y=P(V,W);if(Y==null){return null}let Z=Y.containingObj; let ba=Y.desc;let bb=ba.value; let bc=ba.configurable; let bd=ba.writable;if(!t(m,ba,”value”)){return null}let be=u(null);be.value=bb;if(bc===false&&bd===false||typeof bb!==”function”){return{originals:be}}let bf=F();let bg=F();ba.value=function bh(){let bi=arguments;let bj=bf.notify({args:bi,thisObj:this});if(bj!=null){if(bj.bypassResult!=null){if(bj.bypassResult.throw){throw bj.bypassResult.value}return bj.bypassResult.value}else if(bj.args!=null){bi=bj.args}}let bk;let bl={args:arguments,thisObj:this,threw:true,result:null};try{bk = X&&this instanceof bh ? A(bb,bi) : s(bb,this,bi);bl={args:arguments,thisObj:this,threw:false,result:bk}}finally{let bm=bg.notify(bl);if(bm!=null&&bm.bypassResult!=null){if(bm.bypassResult.throw){throw bm.bypassResult.value}return bm.bypassResult.value}}return bk};let bn=ba.value;h(bn,bb);let bo=p(bb);for(const bq of bo){if(t(y,z,bq)===-1){let br=o(bn,bq);if(br==null||br.configurable===true||br.writable===true){let bs=o(bb,bq);if(bs!=null){q(bn,bq,bs)}}}}try{if(!t(m,bb,”prototype”)){bn.prototype=void 0}}catch{}q(Z,W,ba);return{onBeforeInvoke:bf,onAfterInvoke:bg,originals:be}}function bu(bv,bw){let bx=P(bv,bw);if(bx==null){return null}let by=bx.containingObj; let bz=bx.desc;let bA=bz.value; let bB=bz.get; let bC=bz.set; let bD=bz.configurable;let bE=t(m,bz,”value”);let bF=u(null);if(bD===false||bE){if(bB!=null){bF.get=bB}if(bC!=null){bF.set=bC}if(bE){bF.value=bA}return{originals:bF}}let bG={};if(bB!=null){bF.get=bB;let bH=F();let bI=F();bz.get=function(){let bJ=bH.notify({thisObj:this});if(bJ!=null&&bJ.bypassResult!=null){if(bJ.bypassResult.throw){throw bJ.bypassResult.value}return bJ.bypassResult.value}let bK;let bL={thisObj:this,result:null,threw:true};try{bK=t(bB,this);bL={thisObj:this,result:bK,threw:false}}finally{let bM=bI.notify(bL);if(bM!=null&&bM.bypassResult!=null){if(bM.bypassResult.throw){throw bM.bypassResult.value}return bM.bypassResult.value}}return bK};h(bz.get,bB);try{if(!t(m,bB,”prototype”)){bz.get.prototype=void 0}}catch{}bG.onBeforeGet=bH;bG.onAfterGet=bI}if(bC!=null){bF.set=bC;let bO=F();let bP=F();bz.set=function(bQ){let bR=bQ;let bS=bO.notify({param:bQ,thisObj:this});if(bS!=null){if(bS.bypassResult!=null){if(bS.bypassResult.throw){throw bS.bypassResult.value}return bS.bypassResult.value}else if(t(m,bS,”param”)){bR=bS.param}}let bT;let bU={param:bQ,thisObj:this,result:null,threw:true};try{bT=t(bC,this,bR);bU={param:bQ,thisObj:this,result:bT,threw:false}}finally{let bV=bP.notify(bU);if(bV!=null&&bV.bypassResult!=null){if(bV.bypassResult.throw){throw bV.bypassResult.value}return bV.bypassResult.value}}return bT};h(bz.set,bC);try{if(!t(m,bC,”prototype”)){bz.set.prototype=void 0}}catch{}bG.onBeforeSet=bO;bG.onAfterSet=bP}q(by,bw,bz);bG.originals=bF;return bG}let bX={};let bY=void 0;let bZ=void 0;let ca=void 0;let cb=”‮EWibjQBAF‭”;let cc=”‮YuuMIdcQn‭”;let cd=”-2‮YuuMIdcQn‭”;let ce=void 0;let cf=Object.defineProperty.bind(Object);function cg(ch,ci,cj,ck,cl){if(ck===”function”){bX[ch]=U(cm(cj),ci,!!cl)}else if(ck===”accessor”){bX[ch]=bu(cm(cj),ci)}}function cm(cn){let co=window;for(const element of cn){if(!{}.hasOwnProperty.call(co,element)){return void 0}co=co[element]}return co}cg(“CustomEvent”,”CustomEvent”,[],”function”,true);cg(“cancelBubble”,”cancelBubble”,[“Event”,”prototype”],”accessor”);cg(“fetch”,”fetch”,[],”function”);cg(“formSubmit”,”submit”,[“HTMLFormElement”,”prototype”],”function”);cg(“preventDefault”,”preventDefault”,[“Event”,”prototype”],”function”);cg(“stopImmediatePropagation”,”stopImmediatePropagation”,[“Event”,”prototype”],”function”);cg(“stopPropagation”,”stopPropagation”,[“Event”,”prototype”],”function”);cg(“xhrOpen”,”open”,[“XMLHttpRequest”,”prototype”],”function”);cg(“xhrSend”,”send”,[“XMLHttpRequest”,”prototype”],”function”);(function(){let cq=XMLHttpRequest;if(cq==null){return}let cr=cq.prototype;if(bX.xhrOpen!=null){bY=function(cs){let ct=cs.args==null?null:””+cs.args[0].toLowerCase();Object.defineProperty(cs.thisObj,cb,{writable:true,configurable:true,enumerable:false,value:{method:ct,url:cs.args==null?null:cs.args[1]}});return{args:cs.args}};bX.xhrOpen.onBeforeInvoke.register(bY)}if(bX.xhrSend!=null){bZ=function(cu){if(ce!=null&&cb in cu.thisObj&&ce.shouldHook(cu.thisObj[cb])){let cv=ce.getEncodedData();if(cv){for(let cw in cv){if(!{}.hasOwnProperty.call(cv,cw))continue;let cx=cv[cw];let cy=ce.config.headerNamePrefix+cw;let cz=ce.chunk(cy,cx,ce.config.headerChunkSize);for(let cA in cz){if(!{}.hasOwnProperty.call(cz,cA))continue;cr.setRequestHeader.call(cu.thisObj,cA,cz[cA])}}}}return{args:cu.args}};bX.xhrSend.onBeforeInvoke.register(bZ)}}());(function(){let cB=window.Request;function cC(cD,cE){if(cD.args&&cD.args.length>0){let cF=cD.args[0];let cG=cD.args[1];let cH=new cB(cF,cG);let cI={url:cH.url,method:cH.method};if(ce!=null&&ce.shouldHook(cI)){let cJ=ce.getEncodedData();if(cJ){for(let cK in cJ){if(!{}.hasOwnProperty.call(cJ,cK))continue;let cL=cJ[cK];let cM=ce.config.headerNamePrefix+cK;let cN=ce.chunk(cM,cL,ce.config.headerChunkSize);for(let cO in cN){if(!{}.hasOwnProperty.call(cN,cO))continue;cH.headers.set(cO,cN[cO])}}}}return{args:[cH,cG]}}return cE}if(bX.fetch!=null){bX.fetch.onBeforeInvoke.register(cC)}}());addEventListener(cc,function cP(cQ){ce=cQ.detail;removeEventListener(cc,cP,true)},true);addEventListener(cd,function cR(cS){if(cS.detail!=null&&cS.detail.exchange!=null){if(bX.xhrOpen!=null){bX.xhrOpen.onBeforeInvoke.clear()}if(bX.xhrSend!=null){bX.xhrSend.onBeforeInvoke.clear()}if(bX.fetch!=null){bX.fetch.onBeforeInvoke.clear()}cS.detail.exchange({instrumented:bX})}removeEventListener(cd,cR,true)},true)}(this))}())]]>

Source

Tagged:

Patak’s Squash and Chickpea Korma

Tagged:

Colorado deputy saves choking baby’s life: ‘I did what I needed to do’

Colorado deputy saves choking baby’s life

Deputy Nicholas Pacheco responded to a call of an unresponsive child “turning blue.” LiveNOW from FOX spoke with the deputy about his heroic efforts.

A sheriff’s deputy in Colorado is being hailed a hero after saving a choking infant earlier this week. His efforts were captured on his body camera. 

Deputy Nicholas Pacheco, who has worked for the Arapahoe County Sheriff’s Office for the last eight years, said he responded early on August 13 to a call of an unresponsive one-month-old baby “turning blue.” 

When he arrived on the scene, Pacheco told LiveNOW from FOX that he could tell from the baby boy’s color that he was not breathing and did not appear to be conscious or responsive. 

“She [the mother] hands me the baby and just says, ‘please,’” Pacheco, a father of two children, recalled. 

Body camera footage as the deputy started using cardiopulmonary resuscitation skills to attempt to clear the baby boy’s air pathway. (Credit: Arapahoe Sheriff’s Office)

He immediately started using cardiopulmonary resuscitation skills to attempt to clear the baby boy’s air pathway and resume his breathing.

“I flipped him back and forth between giving him back thrusts and compressions on his chest. He starts coughing up a little bit, starts breathing, and gives out a little bit of cry,” the deputy continued. 

Soon after Pacheco provided several more back thrusts, the baby spit out a white foamy substance, which appeared to be a mixture of milk and infant cereal. 

“He starts crying, his color comes back into his face, and then I tell the parents he’s breathing,” he said. “Soon as the baby started fully crying, you could see the mom stick her hands on her face and let out this gigantic breath sigh of relief.” 

Body camera footage shows the baby being transported to a local hospital for evaluation. (Credit: Arapahoe Sheriff’s Office)

The baby was immediately transported to a local Children’s Hospital for further evaluation. According to the sheriff’s department, the baby, named Carlos, is doing well and is now back at home.

Arapahoe Sheriff’s Office acknowledged Pacheco’s efforts on social media, writing, “Thank you Deputy Pacheco for your quick response and diligence in saving this baby’s life.” 

Pacheco said his sheriff’s office has previously required infant CPR training courses that his instincts of what to do “just kicked in.”

“Thankfully, by the grace of God, I was able to help this baby breathe again.” – Deputy Nicholas Pacheco

“I did what I needed to do, and thankfully, by the grace of God, I was able to help this baby breathe again,” he added. 

Parents and caregivers can find infant and child CPR training at their local Red Cross or fire department. 

This story was reported from Los Angeles.

« Previous Page — Next Page »